FIELD: medicine; oncology.
SUBSTANCE: during taking of cyclophosphan chemotherapy and after it, area of femoral vein is subject to transdermal influence of red non-coherent light with wavelength λ=0,67 mcm. Maximal power of radiation equals to 4 W. Power flux maximal density equals to 7,5 mW/cm2 at continuous mode of operation. Duration of exposure does not exceed 3 minutes.
EFFECT: improved activity of cyclophosphane; prevention of development of metastases; lower chance of leukocytopenia and intoxication.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EXPERIMENTAL TREATMENT OF MALIGNANT NEOPLASMS | 2004 |
|
RU2286811C2 |
| METHOD FOR TREATING MALIGNANT NEOPLASMS UNDER EXPERIMENTAL CONDITIONS | 2003 |
|
RU2261733C2 |
| METHOD OF TREATING MALIGNANT LUNG NEOPLASMS IN EXPERIMENT | 2009 |
|
RU2397790C1 |
| METHOD FOR TREATING CANCER CASES | 2004 |
|
RU2277949C2 |
| METHOD FOR TREATING SKIN NEOPLASMS IN CHILDREN NOT OLDER THAN ONE YEAR | 2003 |
|
RU2240159C1 |
| METHOD OF TREATING SKIN AND SOFT TISSUE HEMANGIOMAS IN INFANTS | 2010 |
|
RU2464053C2 |
| METHOD OF TREATING MALIGNANT NEW GROWTHS IN EXPERIMENT | 2011 |
|
RU2484539C1 |
| METHOD OF TREATMENT OF PULMONARY CANCER | 2008 |
|
RU2388503C1 |
| TREATMENT METHOD OF PATIENTS WITH BREAST CANCER | 2008 |
|
RU2368407C1 |
| METHOD FOR TREATMENT OF MALIGNANT NEOPLASMS USING ELECTROMAGNETIC INFLUENCES IN EXPERIMENT | 2004 |
|
RU2289446C2 |
